tiprankstipranks
Oncolytics Biotech (ONCY)
NASDAQ:ONCY
US Market

Compare Oncolytics Biotech (ONCY) vs. Competitors

1,543 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Oncolytics Biotech
$0.93
$108.00M
-2.91
86.00%
3 Buy
2 Hold
0 Sell
Moderate Buy
Atossa Therapeutics
$4.94
$42.54M
-2.19
-44.15%
3 Buy
0 Hold
0 Sell
Strong Buy
Oramed Pharm
$2.91
$142.78M
1.57
65.73%
Atara Biotherapeutics
$15.79
$38.03M
-16.66
-12.26%
1 Buy
1 Hold
0 Sell
Moderate Buy
Zentalis Pharmaceuticals
$1.41
$468.85M
-0.71
484.96%
4 Buy
1 Hold
0 Sell
Strong Buy
Prelude Therapeutics
$2.45
$257.05M
-2.24
536.51%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ONCY
Oncolytics Biotech
0.93
0.31
49.52%
ATOS
Atossa Therapeutics
4.94
-4.75
-49.02%
ORMP
Oramed Pharm
3.53
1.56
79.46%
ATRA
Atara Biotherapeutics
4.65
-0.88
-15.91%
ZNTL
Zentalis Pharmaceuticals
6.61
5.38
437.40%
PRLD
Prelude Therapeutics
4.08
3.37
474.65%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts